Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Chen, Qiaozhen
Liu, Weibo
Jiang, Biao
Yu, Risheng
Li, Xiuzhen
and
Li, Huichun
2012.
Fluoxetine-responsive depression in a Chinese cerebrotendinous xanthomatosis.
General Hospital Psychiatry,
Vol. 34,
Issue. 5,
p.
578.e1.
van Karnebeek, Clara D.M.
and
Stockler, Sylvia
2012.
Treatable inborn errors of metabolism causing intellectual disability: A systematic literature review.
Molecular Genetics and Metabolism,
Vol. 105,
Issue. 3,
p.
368.
Fraidakis, M J
2013.
Psychiatric manifestations in cerebrotendinous xanthomatosis.
Translational Psychiatry,
Vol. 3,
Issue. 9,
p.
e302.
Pandolfo, Massimo
and
Manto, Mario
2013.
Cerebellar and Afferent Ataxias.
CONTINUUM: Lifelong Learning in Neurology,
Vol. 19,
Issue. ,
p.
1312.
Yahalom, Gilad
Tsabari, Rakefet
Molshatzki, Noa
Ephraty, Lilach
Cohen, Hofit
and
Hassin-Baer, Sharon
2013.
Neurological Outcome in Cerebrotendinous Xanthomatosis Treated With Chenodeoxycholic Acid.
Clinical Neuropharmacology,
Vol. 36,
Issue. 3,
p.
78.
Cascales, T.
and
Baruteau, J.
2013.
Prise en charge psychologique des enfants avec une maladie héréditaire du métabolisme.
Neuropsychiatrie de l'Enfance et de l'Adolescence,
Vol. 61,
Issue. 4,
p.
259.
Bonnot, O.
2013.
Formes organiques des pathologies psychiatriques : l’exemple des maladies neurométaboliques.
European Psychiatry,
Vol. 28,
Issue. S2,
p.
14.
Boustany, Rose-Mary
Al-Shareef, Ibraheem
and
El-Haddad, Sariah
2013.
Emery and Rimoin's Principles and Practice of Medical Genetics.
p.
1.
Demily, Caroline
and
Sedel, Frédéric
2014.
Psychiatric manifestations of treatable hereditary metabolic disorders in adults.
Annals of General Psychiatry,
Vol. 13,
Issue. 1,
Luyckx, Evelien
Eyskens, François
Simons, Annik
Beckx, Katrien
Van West, Dirk
and
Dhar, Monica
2014.
Long-term follow-up on the effect of combined therapy of bile acids and statins in the treatment of cerebrotendinous xanthomatosis: A case report.
Clinical Neurology and Neurosurgery,
Vol. 118,
Issue. ,
p.
9.
van de Warrenburg, B. P. C.
van Gaalen, J.
Boesch, S.
Burgunder, J.‐M.
Dürr, A.
Giunti, P.
Klockgether, T.
Mariotti, C.
Pandolfo, M.
and
Riess, O.
2014.
EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood.
European Journal of Neurology,
Vol. 21,
Issue. 4,
p.
552.
Bonnot, Olivier
Herrera, Paula
and
Kuster, Alice
2015.
Maladies neurométaboliques traitables associées aux troubles du spectre de la schizophrénie.
La Presse Médicale,
Vol. 44,
Issue. 9,
p.
889.
Degos, Bertrand
Nadjar, Yann
Amador, Maria del Mar
Lamari, Foudil
Sedel, Frédéric
Roze, Emmanuel
Couvert, Philippe
and
Mochel, Fanny
2016.
Natural history of cerebrotendinous xanthomatosis: a paediatric disease diagnosed in adulthood.
Orphanet Journal of Rare Diseases,
Vol. 11,
Issue. 1,
Bonnot, O.
2017.
Maladies neurométaboliques. Un nouveau champ d’intérêt pour la psychiatrie de l’enfant et de l’adolescent.
Neuropsychiatrie de l'Enfance et de l'Adolescence,
Vol. 65,
Issue. 2,
p.
110.
Abdel-Hamid, Mohamed S.
Issa, Mahmoud Y.
Otaify, Ghada A.
and
Zaki, Maha S.
2017.
A novel frameshift mutation in the sterol 27-hydroxylase gene in an Egyptian family with cerebrotendinous xanthomatosis without cataract.
Metabolic Brain Disease,
Vol. 32,
Issue. 2,
p.
311.
Alhariri, Ahmad
Hamilton, Katherine
Oza, Vikash
Cordoro, Kelly
Sobreira, Nara L.
Malloy, Mary
and
Slavotinek, Anne
2017.
Clinical report: A patient with a late diagnosis of cerebrotendinous xanthomatosis and a response to treatment.
American Journal of Medical Genetics Part A,
Vol. 173,
Issue. 8,
p.
2275.
Matsumoto, Mitsuyuki
Walton, Noah M.
Yamada, Hiroshi
Kondo, Yuji
Marek, Gerard J.
and
Tajinda, Katsunori
2017.
The impact of genetics on future drug discovery in schizophrenia.
Expert Opinion on Drug Discovery,
Vol. 12,
Issue. 7,
p.
673.
Wong, Janice C.
Walsh, Kailey
Hayden, Douglas
and
Eichler, Florian S.
2018.
Natural history of neurological abnormalities in cerebrotendinous xanthomatosis.
Journal of Inherited Metabolic Disease,
Vol. 41,
Issue. 4,
p.
647.
Stelten, Bianca M.L.
Huidekoper, Hidde H.
van de Warrenburg, Bart P.C.
Brilstra, Eva H.
Hollak, Carla E.M.
Haak, Harm.R.
Kluijtmans, Leo A.J.
Wevers, Ron A.
and
Verrips, Aad
2019.
Long-term treatment effect in cerebrotendinous xanthomatosis depends on age at treatment start.
Neurology,
Vol. 92,
Issue. 2,
Dell'Aversano Orabona, Giuseppina
Dato, Clemente
Oliva, Mariano
Ugga, Lorenzo
Dotti, Maria Teresa
Fratta, Mario
and
Gisonni, Pietro
2020.
Multi-imaging study in a patient with cerebrotendinous xanthomatosis: radiology, clinic and pathology correlation of a rare condition.
BJR|case reports,
Vol. 6,
Issue. 1,
p.
20190047.